Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 4, 2000

View Archived Issues

MedImmune moves three new products into the clinic in 1999

Wyeth-Ayerst makes EAAT-related milestone payment to Neurocrine Biosciences

Oculex updates intraocular drug delivery pipeline

Sporanox Injection now available for treatment of serious fungal infections

Atrix reports progress in Atrigel leuprolide formulations

Avonex MS trial stopped early, results positive

Amarillo Biosciences' oral interferon alfa granted orphan drug status for Behcet's disease

AEterna to commence phase III trial of AE-941 in second cancer indication

Teva signs definitive agreement to acquire Novopharm

Telithromycin featured in multiple presentations at ICMASKO 5

Berlex seeks FDA approval of long-acting intrauterine contraceptive

Memantine diminishes pain in diabetic neuropathy

InKine files patent for novel antiangiogenic protein

InterMune begins phase II trial of Actimmune in cryptococcal meningitis

Bexarotene now on the market in U.S.

COX-2 inhibitor now available for FAP indication

Cognetix, Elan team up to develop novel analgesic/drug delivery system

Novel foscarnet prodrugs show significantly enhanced activity against drug-resistant HIV

Novel analgesic compounds reported by Gruenenthal

Antitumor epothilone derivatives reported in patent literature by Schering AG

Draxis initiates phase III clinical trials with Fibrimage

New agents for imaging, treating angiogenic disorders under study at DuPont Pharmaceuticals

BMS prepares new tryptase inhibitors particularly useful for asthma

Newly patented hydrazine derivatives from Roche inhibit TNF-alpha release

RenaGel receives marketing approval in the E.U.

Medicure receives patent allowance for new antihypertensive drug

News from ICMASKO 5: Pliva describes new azalides

Oral valganciclovir is as effective as i.v. ganciclovir, with fewer complications

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...